Evidence map›Paper›PMID 41860313›Full record

ArticleTranslational vision science & technology2026

Storage of Corneas With Predissected Descemet Membrane in an Active Storage Machine.

Paul Goin, Sylvain Poinard, Oliver Dorado, Chantal Perrache, Zhiguo He, Sandrine Ninotta, Philippe Gain, Anne-Sophie Gauthier, Gilles Thuret

Abstract read
In one paragraph

Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul GoinLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Sylvain PoinardLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Oliver DoradoLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Chantal PerracheLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Zhiguo HeLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Sandrine NinottaLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Philippe GainLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.
Anne-Sophie GauthierDepartment of Ophthalmology, University Hospital of Besançon, France.
Gilles ThuretLaboratory Biology, Engineering and Imaging for Ophthalmology, BiiO, Faculty of Medicine, Health and Innovation Campus, Jean Monnet University, Saint-Etienne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We previously demonstrated the superiority of an active storage machine (ASM; which restores a physiologic intraocular pressure [IOP]) over conventional passive storage for whole corneas. To reduce surgical time, corneas are often predissected in eye banks, 2 to 4 days before surgery for endothelial keratoplasty. The aim is here to demonstrate the possibility of also storing predissected Descemet membrane endothelial keratoplasty (DMEK) in ASM so that their use is not limited to penetrating keratoplasty and to extend the storage life of these endothelial grafts for much more flexibility. Methods: In this preclinical study, pairs of human corneas were predissected, leaving the Descemet membrane attached only by a small central area. After randomization, they were stored in the same commercial organ culture medium, either in the ASM (21 millimeters of mercury [mm Hg], 2.6 µL/min) or in a sealed flask, for 3 or 10 days. Final assessment consisted of measuring the viable endothelial cell density (ECD), corneal thickness, and assessing the expression of CD166 and NCAM, ZO-1 (morphology and junctions), Na+/K+ATPase (endothelial pump) and COX-IV (mitochondria) by immunostaining. Results: Final endothelial cell (EC) viability was comparable between the two groups for both storage periods, as were the markers studied by immunofluorescence. However, corneal thickness was lower in the ASM group. Conclusions: In conclusion, the ASM can be used for predissected DMEK for at least 10 days, thus enabling to organize runs of graft preparation and subsequent safe storage while simplifying logistics. Translational Relevance: ASM can be used to preserve pre-cut DMEK grafts, providing greater flexibility in surgical planning. Objectif: Nous avons précédemment démontré la supériorité d'un dispositif de stockage actif (ASM, qui rétablit une pression intraoculaire physiologique) par rapport au stockage passif conventionnel pour les cornées entières. Afin de réduire la durée de la chirurgie, les cornées sont souvent prédécoupées dans les banques de tissus, 2 à 4 jours avant la chirurgie, pour une greffe endothéliale. L'objectif ici est de démontrer la possibilité de stocker également des DMEK prédécoupées dans l'ASM afin que son utilisation ne se limite pas à la kératoplastie transfixiante et de prolonger la durée de conservation de ces greffons endothéliaux pour une plus grande flexibilité. Méthodes: Dans cette étude préclinique, des paires de cornées humaines ont été prédisséquées, en laissant l'endothélium attaché seulement par une petite zone centrale. Après randomisation, elles ont été conservées dans le même milieu commercial d'organoculture, soit dans l'ASM (21 mmHg, 2,6 µL/min), soit dans un flacon scellé, pendant 3 ou 10 jours. L'évaluation finale a consisté à mesurer la densité cellulaire endothéliale viable, l'épaisseur de la cornée, et à évaluer l'expression de CD166 et NCAM, ZO-1 (morphologie et jonctions), Na+/K+ATPase (pompe endothéliale) et COX-IV (mitochondries) par immunomarquage. Résultats: La viabilité cellulaire endothéliale finale était comparable entre les deux groupes pour les deux périodes de conservation, tout comme les marqueurs étudiés par immunofluorescence. Cependant, l'épaisseur cornéenne était plus faible dans le groupe ASM. Conclusions: En conclusion, l'ASM peut être utilisée pour les DMEK prédécoupées pendant au moins 10 jours, ce qui permet d'organiser des séries de préparation de greffons et leur stockage ultérieur en toute sécurité, tout en simplifiant la logistique. Pertinence translationnelle: L'ASM peut être utilisé pour préserver des greffons de DMEK prédécoupés et ainsi apporter plus de flexibilité dans l'organisation d'une chirurgie.

Indexed as

CorneaDescemet MembraneDescemet Stripping Endothelial KeratoplastyEye BanksOrgan PreservationCell CountCell SurvivalEndothelium, CornealHumans

Identifiers

PMID41860313
PMCPMC13020131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.